Venous Thromboembolism in Pregnancy: Challenges and Solutions.
Dimitrios VarriasMichail SpanosDamianos G KokkinidisPanagiotis ZoumpourlisDimitrios Rafail KalaitzopoulosPublished in: Vascular health and risk management (2023)
Venous thromboembolism (VTE) is a serious medical condition that can lead to severe morbidity and mortality, making it a significant public health concern. VTE is a multifactorial condition that results from the interaction of genetic, acquired, and environmental factors. Physiological changes during pregnancy increase the risk of VTE as they express Virchow's triad (increased coagulation factors, decreased fibrinolysis, trauma, and venous stasis). Moreover, pregnancy-related risk factors, such as advanced maternal age, obesity, multiple gestations, and cesarean delivery, further increase the risk of VTE. Managing VTE in pregnancy is challenging due to the complexity of balancing the risks and benefits of anticoagulant therapy for both the mother and the fetus. A multidisciplinary approach involving obstetricians, hematologists, and neonatologists, is necessary to ensure optimal outcomes for both the mother and baby. This review aims to discuss the current challenges associated with VTE in pregnancy and identify potential solutions for improving outcomes for pregnant women at risk for VTE.
Keyphrases
- venous thromboembolism
- pregnancy outcomes
- direct oral anticoagulants
- pregnant women
- public health
- preterm birth
- healthcare
- type diabetes
- metabolic syndrome
- insulin resistance
- weight loss
- skeletal muscle
- physical activity
- human health
- genome wide
- body mass index
- weight gain
- dna methylation
- high fat diet induced
- adipose tissue
- birth weight
- quality improvement
- global health
- trauma patients